Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Activated Partial Thromboplastin Time versus Anti-Factor Xa Levels for Monitoring Unfractionated Heparin Therapy in Children: An Institutional Experience.

Woods GM, Stanek J, Harrison S, Texter K, Kerlin BA, Dunn AL, Kumar R.

J Pediatr Hematol Oncol. 2017 Oct;39(7):576-577. doi: 10.1097/MPH.0000000000000966. No abstract available.

PMID:
28902081
2.

The toll-like receptor ligands Hiltonol® (polyICLC) and imiquimod effectively activate antigen-specific immune responses in Tasmanian devils (Sarcophilus harrisii).

Patchett AL, Tovar C, Corcoran LM, Lyons AB, Woods GM.

Dev Comp Immunol. 2017 Nov;76:352-360. doi: 10.1016/j.dci.2017.07.004. Epub 2017 Jul 6.

PMID:
28689773
3.

The absence of TNF permits myeloid Arginase 1 expression in experimental L. monocytogenes infection.

Li X, Lyons AB, Woods GM, Körner H.

Immunobiology. 2017 Aug;222(8-9):913-917. doi: 10.1016/j.imbio.2017.05.012. Epub 2017 May 16.

PMID:
28545808
4.

Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease.

Flies AS, Blackburn NB, Lyons AB, Hayball JD, Woods GM.

Front Immunol. 2017 May 3;8:513. doi: 10.3389/fimmu.2017.00513. eCollection 2017.

5.

Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils.

Tovar C, Pye RJ, Kreiss A, Cheng Y, Brown GK, Darby J, Malley RC, Siddle HV, Skjødt K, Kaufman J, Silva A, Baz Morelli A, Papenfuss AT, Corcoran LM, Murphy JM, Pearse MJ, Belov K, Lyons AB, Woods GM.

Sci Rep. 2017 Mar 9;7:43827. doi: 10.1038/srep43827.

6.

Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.

Pye R, Hamede R, Siddle HV, Caldwell A, Knowles GW, Swift K, Kreiss A, Jones ME, Lyons AB, Woods GM.

Biol Lett. 2016 Oct;12(10). pii: 20160553. doi: 10.1098/rsbl.2016.0553.

7.

PD-L1 Is Not Constitutively Expressed on Tasmanian Devil Facial Tumor Cells but Is Strongly Upregulated in Response to IFN-γ and Can Be Expressed in the Tumor Microenvironment.

Flies AS, Lyons AB, Corcoran LM, Papenfuss AT, Murphy JM, Knowles GW, Woods GM, Hayball JD.

Front Immunol. 2016 Dec 9;7:581. doi: 10.3389/fimmu.2016.00581. eCollection 2016.

8.

The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines.

Patchett AL, Darby JM, Tovar C, Lyons AB, Woods GM.

PLoS One. 2016 Dec 9;11(12):e0168068. doi: 10.1371/journal.pone.0168068. eCollection 2016.

9.

Pediatric Oral/Maxillofacial Soft Tissue Sarcomas: A Clinicopathologic Report of Four Cases.

Thompson JC, Woods GM, Arnold MA, Elmaraghy C, Kahwash SB, Cripe TP, Setty BA.

Case Rep Oncol. 2016 Aug 17;9(2):447-453. eCollection 2016 May-Aug.

10.

Discovery of Biomarkers for Tasmanian Devil Cancer (DFTD) by Metabolic Profiling of Serum.

Karu N, Wilson R, Hamede R, Jones M, Woods GM, Hilder EF, Shellie RA.

J Proteome Res. 2016 Oct 7;15(10):3827-3840. Epub 2016 Sep 23.

PMID:
27599268
11.

Light Transmission Aggregometry Does Not Correlate With the Severity of δ-Granule Platelet Storage Pool Deficiency.

Woods GM, Kudron EL, Davis K, Stanek J, Kerlin BA, O'Brien SH.

J Pediatr Hematol Oncol. 2016 Oct;38(7):525-8. doi: 10.1097/MPH.0000000000000638.

PMID:
27403770
12.

Fucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.

Atashrazm F, Lowenthal RM, Dickinson JL, Holloway AF, Woods GM.

Oncotarget. 2016 Jul 19;7(29):46028-46041. doi: 10.18632/oncotarget.10016.

13.

Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.

Brown GK, Tovar C, Cooray AA, Kreiss A, Darby J, Murphy JM, Corcoran LM, Bettiol SS, Lyons AB, Woods GM.

Immunol Cell Biol. 2016 Aug;94(7):673-9. doi: 10.1038/icb.2016.38. Epub 2016 Apr 19.

PMID:
27089941
14.

A second transmissible cancer in Tasmanian devils.

Pye RJ, Pemberton D, Tovar C, Tubio JM, Dun KA, Fox S, Darby J, Hayes D, Knowles GW, Kreiss A, Siddle HV, Swift K, Lyons AB, Murchison EP, Woods GM.

Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):374-9. doi: 10.1073/pnas.1519691113. Epub 2015 Dec 28.

15.

Devil Facial Tumor Disease.

Pye RJ, Woods GM, Kreiss A.

Vet Pathol. 2016 Jul;53(4):726-36. doi: 10.1177/0300985815616444. Epub 2015 Dec 13. Review.

PMID:
26657222
16.

Fucoidan Suppresses the Growth of Human Acute Promyelocytic Leukemia Cells In Vitro and In Vivo.

Atashrazm F, Lowenthal RM, Woods GM, Holloway AF, Karpiniec SS, Dickinson JL.

J Cell Physiol. 2016 Mar;231(3):688-97. doi: 10.1002/jcp.25119.

PMID:
26241708
17.

Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil.

Patchett AL, Latham R, Brettingham-Moore KH, Tovar C, Lyons AB, Woods GM.

Dev Comp Immunol. 2015 Nov;53(1):123-33. doi: 10.1016/j.dci.2015.07.003. Epub 2015 Jul 13.

PMID:
26182986
18.

Immunology of a Transmissible Cancer Spreading among Tasmanian Devils.

Woods GM, Howson LJ, Brown GK, Tovar C, Kreiss A, Corcoran LM, Lyons AB.

J Immunol. 2015 Jul 1;195(1):23-9. doi: 10.4049/jimmunol.1500131. Review.

19.

A Review of Hormonal Contraception and Venous Thromboembolism in Adolescents.

Woods GM, Kerlin BA, O'Brien SH, Bonny AE.

J Pediatr Adolesc Gynecol. 2016 Oct;29(5):402-408. doi: 10.1016/j.jpag.2015.05.007. Epub 2015 May 30. Review.

PMID:
27491960
20.

Fucoidan and cancer: a multifunctional molecule with anti-tumor potential.

Atashrazm F, Lowenthal RM, Woods GM, Holloway AF, Dickinson JL.

Mar Drugs. 2015 Apr 14;13(4):2327-46. doi: 10.3390/md13042327. Review.

21.

Radiation therapy may increase metastatic potential in alveolar rhabdomyosarcoma.

Woods GM, Bondra K, Chronowski C, Leasure J, Singh M, Hensley L, Cripe TP, Chakravarti A, Houghton P.

Pediatr Blood Cancer. 2015 Sep;62(9):1550-1554. doi: 10.1002/pbc.25516. Epub 2015 Mar 19.

22.

Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.

Kreiss A, Brown GK, Tovar C, Lyons AB, Woods GM.

Vaccine. 2015 Jun 12;33(26):3016-25. doi: 10.1016/j.vaccine.2015.01.039. Epub 2015 Feb 20.

23.

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS Jr, Hirtz D, Casella JF.

N Engl J Med. 2014 Aug 21;371(8):699-710. doi: 10.1056/NEJMoa1401731.

24.

Silent cerebral infarction, income, and grade retention among students with sickle cell anemia.

King AA, Rodeghier MJ, Panepinto JA, Strouse JJ, Casella JF, Quinn CT, Dowling MM, Sarnaik SA, Thompson AA, Woods GM, Minniti CP, Redding-Lallinger RC, Kirby-Allen M, Kirkham FJ, McKinstry R, Noetzel MJ, White DA, Kwiatkowski JK, Howard TH, Kalinyak KA, Inusa B, Rhodes MM, Heiny ME, Fuh B, Fixler JM, Gordon MO, DeBaun MR.

Am J Hematol. 2014 Oct;89(10):E188-92. doi: 10.1002/ajh.23805. Epub 2014 Aug 4.

25.

Mouse Model of Devil Facial Tumour Disease Establishes That an Effective Immune Response Can be Generated Against the Cancer Cells.

Pinfold TL, Brown GK, Bettiol SS, Woods GM.

Front Immunol. 2014 May 27;5:251. doi: 10.3389/fimmu.2014.00251. eCollection 2014.

26.

Secondary Acute Myeloid Leukemia in a One-Year-Old Girl Diagnosed with JAK2-V617F Mutation Positive Myeloproliferative Neoplasm.

Woods GM, Bajwa RP, Kahwash SB, Guinipero T.

Case Rep Med. 2014;2014:473297. doi: 10.1155/2014/473297. Epub 2014 Mar 18.

27.

Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors.

Howson LJ, Morris KM, Kobayashi T, Tovar C, Kreiss A, Papenfuss AT, Corcoran L, Belov K, Woods GM.

Anat Rec (Hoboken). 2014 May;297(5):925-38. doi: 10.1002/ar.22904. Epub 2014 Mar 24.

28.

Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancer.

Siddle HV, Kreiss A, Tovar C, Yuen CK, Cheng Y, Belov K, Swift K, Pearse AM, Hamede R, Jones ME, Skjødt K, Woods GM, Kaufman J.

Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5103-8. doi: 10.1073/pnas.1219920110. Epub 2013 Mar 11.

29.

Ultraviolet radiation effects on the proteome of skin cells.

Muller HK, Woods GM.

Adv Exp Med Biol. 2013;990:111-9. doi: 10.1007/978-94-007-5896-4_8. Review.

PMID:
23378007
30.

Anti-PML-RARα shRNA sensitises promyelocytic leukaemia cells to all-trans retinoic acid.

Casey NP, Woods GM.

J RNAi Gene Silencing. 2012;8:464-9. Epub 2012 Jul 13.

31.

Dietary vitamin D alters the response of the skin to UVB-irradiation depending on the genetic background of the mice.

Malley RC, Muller HK, Norval M, Woods GM.

Photochem Photobiol Sci. 2013 Mar;12(3):536-45. doi: 10.1039/c2pp25211b.

PMID:
23258584
32.

Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer.

Murchison EP, Schulz-Trieglaff OB, Ning Z, Alexandrov LB, Bauer MJ, Fu B, Hims M, Ding Z, Ivakhno S, Stewart C, Ng BL, Wong W, Aken B, White S, Alsop A, Becq J, Bignell GR, Cheetham RK, Cheng W, Connor TR, Cox AJ, Feng ZP, Gu Y, Grocock RJ, Harris SR, Khrebtukova I, Kingsbury Z, Kowarsky M, Kreiss A, Luo S, Marshall J, McBride DJ, Murray L, Pearse AM, Raine K, Rasolonjatovo I, Shaw R, Tedder P, Tregidgo C, Vilella AJ, Wedge DC, Woods GM, Gormley N, Humphray S, Schroth G, Smith G, Hall K, Searle SM, Carter NP, Papenfuss AT, Futreal PA, Campbell PJ, Yang F, Bentley DR, Evers DJ, Stratton MR.

Cell. 2012 Feb 17;148(4):780-91. doi: 10.1016/j.cell.2011.11.065.

33.

Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.

Kwiatkowski JL, Cohen AR, Garro J, Alvarez O, Nagasubramanian R, Sarnaik S, Thompson A, Woods GM, Schultz W, Mortier N, Lane P, Mueller B, Yovetich N, Ware RE; SWiTCH Study Investigators.

Am J Hematol. 2012 Feb;87(2):221-3. doi: 10.1002/ajh.22228. Epub 2011 Nov 25.

34.

Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.

DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT, Kirby-Allen M, Quinn CT, Bernaudin F, Airewele G, Woods GM, Panepinto JA, Fuh B, Kwiatkowski JK, King AA, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Sabio H, Gonzalez CE, Saccente SL, Kalinyak KA, Strouse JJ, Fixler JM, Gordon MO, Miller JP, Noetzel MJ, Ichord RN, Casella JF.

Blood. 2012 Apr 19;119(16):3684-90. doi: 10.1182/blood-2011-05-349621. Epub 2011 Nov 17.

35.

Natural killer cell mediated cytotoxic responses in the Tasmanian devil.

Brown GK, Kreiss A, Lyons AB, Woods GM.

PLoS One. 2011;6(9):e24475. doi: 10.1371/journal.pone.0024475. Epub 2011 Sep 21.

36.

Oxidant-mediated modification of the cellular thiols is sufficient for arginase activation in cultured cells.

Iyamu EW, Perdew HA, Woods GM.

Mol Cell Biochem. 2012 Jan;360(1-2):159-68. doi: 10.1007/s11010-011-1053-5. Epub 2011 Sep 15.

PMID:
21918827
37.

Allorecognition in the Tasmanian devil (Sarcophilus harrisii), an endangered marsupial species with limited genetic diversity.

Kreiss A, Cheng Y, Kimble F, Wells B, Donovan S, Belov K, Woods GM.

PLoS One. 2011;6(7):e22402. doi: 10.1371/journal.pone.0022402. Epub 2011 Jul 21.

38.

UV-induced immunosuppression and the efficacy of vaccination.

Norval M, Woods GM.

Photochem Photobiol Sci. 2011 Aug;10(8):1267-74. doi: 10.1039/c1pp05105a. Epub 2011 Jun 28. Review.

PMID:
21713277
39.

Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil).

Miller W, Hayes VM, Ratan A, Petersen DC, Wittekindt NE, Miller J, Walenz B, Knight J, Qi J, Zhao F, Wang Q, Bedoya-Reina OC, Katiyar N, Tomsho LP, Kasson LM, Hardie RA, Woodbridge P, Tindall EA, Bertelsen MF, Dixon D, Pyecroft S, Helgen KM, Lesk AM, Pringle TH, Patterson N, Zhang Y, Kreiss A, Woods GM, Jones ME, Schuster SC.

Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12348-53. doi: 10.1073/pnas.1102838108. Epub 2011 Jun 27. Erratum in: Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18625.

40.

Tumor-specific diagnostic marker for transmissible facial tumors of Tasmanian devils: immunohistochemistry studies.

Tovar C, Obendorf D, Murchison EP, Papenfuss AT, Kreiss A, Woods GM.

Vet Pathol. 2011 Nov;48(6):1195-203. doi: 10.1177/0300985811400447. Epub 2011 Mar 7.

PMID:
21383118
41.

Neonatal exposure to UVR alters skin immune system development, and suppresses immunity in adulthood.

McGee HM, Malley RC, Muller HK, Woods GM.

Immunol Cell Biol. 2011 Oct;89(7):767-76. doi: 10.1038/icb.2010.170. Epub 2011 Jan 18.

PMID:
21243005
42.

Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.

Hulbert ML, McKinstry RC, Lacey JL, Moran CJ, Panepinto JA, Thompson AA, Sarnaik SA, Woods GM, Casella JF, Inusa B, Howard J, Kirkham FJ, Anie KA, Mullin JE, Ichord R, Noetzel M, Yan Y, Rodeghier M, Debaun MR.

Blood. 2011 Jan 20;117(3):772-9. doi: 10.1182/blood-2010-01-261123. Epub 2010 Oct 12.

43.

A murine xenograft model for a transmissible cancer in Tasmanian devils.

Kreiss A, Tovar C, Obendorf DL, Dun K, Woods GM.

Vet Pathol. 2011 Mar;48(2):475-81. doi: 10.1177/0300985810380398. Epub 2010 Sep 22.

PMID:
20861503
44.

Mutation in erythroid specific transcription factor KLF1 causes Hereditary Spherocytosis in the Nan hemolytic anemia mouse model.

Heruth DP, Hawkins T, Logsdon DP, Gibson MI, Sokolovsky IV, Nsumu NN, Major SL, Fegley B, Woods GM, Lewing KB, Neville KA, Cornetta K, Peterson KR, White RA.

Genomics. 2010 Nov;96(5):303-7. doi: 10.1016/j.ygeno.2010.07.009. Epub 2010 Aug 5.

45.

The two faces of metallothionein in carcinogenesis: photoprotection against UVR-induced cancer and promotion of tumour survival.

McGee HM, Woods GM, Bennett B, Chung RS.

Photochem Photobiol Sci. 2010 Apr;9(4):586-96. doi: 10.1039/b9pp00155g. Review.

PMID:
20354655
46.

The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer.

Murchison EP, Tovar C, Hsu A, Bender HS, Kheradpour P, Rebbeck CA, Obendorf D, Conlan C, Bahlo M, Blizzard CA, Pyecroft S, Kreiss A, Kellis M, Stark A, Harkins TT, Marshall Graves JA, Woods GM, Hannon GJ, Papenfuss AT.

Science. 2010 Jan 1;327(5961):84-7. doi: 10.1126/science.1180616.

47.

Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.

Adamkiewicz TV, Abboud MR, Paley C, Olivieri N, Kirby-Allen M, Vichinsky E, Casella JF, Alvarez OA, Barredo JC, Lee MT, Iyer RV, Kutlar A, McKie KM, McKie V, Odo N, Gee B, Kwiatkowski JL, Woods GM, Coates T, Wang W, Adams RJ.

Blood. 2009 Nov 19;114(21):4632-8. doi: 10.1182/blood-2009-02-203323. Epub 2009 Aug 31.

48.

Solar simulated ultraviolet radiation damages murine neonatal skin and alters Langerhans cell development, but does not induce inflammation.

McGee HM, Dharmadasa T, Woods GM.

Photochem Photobiol Sci. 2009 Jun;8(6):881-6. doi: 10.1039/b822591e. Epub 2009 May 11.

PMID:
19492117
49.

A histological and immunohistochemical analysis of lymphoid tissues of the Tasmanian devil.

Kreiss A, Obendorf DL, Hemsley S, Canfield PJ, Woods GM.

Anat Rec (Hoboken). 2009 May;292(5):611-20. doi: 10.1002/ar.20896.

50.

The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against horse red blood cells.

Kreiss A, Wells B, Woods GM.

Vet Immunol Immunopathol. 2009 Jul 15;130(1-2):135-7. doi: 10.1016/j.vetimm.2009.02.003. Epub 2009 Feb 11.

PMID:
19264365

Supplemental Content

Loading ...
Support Center